BALAXI PHARMACEUTICALS
Back to All Ratios
|
BALAXI PHARMACEUTICALS Last 5 Year Return on Capital Employed (ROCE) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| ROCE(%) | 13.01 | 2.31 | 37.46 | 59.62 | 92.56 |
What is the latest Return on Capital Employed (ROCE) ratio of BALAXI PHARMACEUTICALS ?
| Year | Return on Capital Employed (ROCE) |
|---|---|
| Mar2025 | 13.01 |
| Mar2024 | 2.31 |
| Mar2023 | 37.46 |
| Mar2022 | 59.62 |
| Mar2021 | 92.56 |
How is Return on Capital Employed (ROCE) of BALAXI PHARMACEUTICALS Trending?
| Years | Return on Capital Employed (ROCE) | % Change | |
|---|---|---|---|
| Mar2025 | 13.01 | 463.20 | |
| Mar2024 | 2.31 | -93.83 | |
| Mar2023 | 37.46 | -37.17 | |
| Mar2022 | 59.62 | -35.59 | |
| Mar2021 | 92.56 | - | |
Other Financial Ratios of BALAXI PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Return on Capital Employed (ROCE) ratio of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹127.6 Cr | -2.2% | -8.9% | -53.1% | Stock Analytics | |
| ADANI ENTERPRISES | ₹395,480.0 Cr | 0% | 2.3% | 30.8% | Stock Analytics | |
| PREMIER ENERGIES | ₹47,651.3 Cr | -2.8% | 3.3% | 8.8% | Stock Analytics | |
| ADITYA INFOTECH | ₹41,932.4 Cr | -2.2% | 34.4% | NA | Stock Analytics | |
| AEGIS LOGISTICS | ₹40,029.8 Cr | 13.1% | 59.5% | 32.7% | Stock Analytics | |
| REDINGTON | ₹22,386.1 Cr | 1.9% | 27.5% | -5.1% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -2.2% |
-8.9% |
-53.1% |
| SENSEX | -0.4% |
0.8% |
-5.3% |
You may also like the below Video Courses